<p>(A) Schema of the constructs used for C2C12 cell co-transfection. The target plasmid is the bicistronic dual luciferase vector with the FGF1 promoter and IRES. The effector plasmids express p54<sup>nrb</sup> (p54) or hnRNPM (HM), or co-express p54<sup>nrb</sup> and hnRNPM. The latter plasmid is a bicistronic contruct containing the FGF1 IRES. (B) Western blots of transfected proliferating C2C12 cell extracts using antibodies against p54(αHM), hnRNPM (αHM) of GAPDH as a control (αGAPDH). (C-E) Luciferase activities measurement of co-transfected proliferating or differentiating C2C12 cell extracts. LucR activity reflects the FGF1 mRNA promoter activity (as cap-dependent translation does not significantly vary, as shown by RNA transfection,...
<p>Luciferase reporter bearing 3 copies of ARE (<b>A</b>)<b>,</b> or GCLM-luciferase reporter (<b>B<...
<p>(<b>A</b>) Schematic of the experimental design. B1 and B2 SINE expression constructs were co-tra...
Several gene therapy applications require the transfer and simultaneous expression of multiple genes...
<p>C2C12 cells were first transfected with bicistronic plasmids and 48h later with siRNAs targeting ...
<p>(A) RT qPCR quantification of endogenous FGF1 mRNA A was performed as described in Mat. & Meth. d...
<p>C2C12 cells were transfected with bicistronic plasmids containing either the complete promoter 1A...
<p>(A, C, E) C2C12 cells were transfected with bicistronic plasmids containing either the FGF1 IRES,...
<p>A) Vero cells were co-transfected with the NF-κB reporter and either each of the different PB1-F2...
<p>(A, B) Suppression of co-transfected reporters in HeLa cells (A) and mouse 3T3 cells (B). Cells w...
<p>(<b>A–B</b>) Relative NF-κB activity after co-transfection of pNF-κB-Luc and p22-FLIP plasmid wit...
<p>(<b>A, B, C, D and E</b>) The fluorescent images were captured of cells transfected with either v...
<p>(A) Pathways activated by NR4A1 and targeted by NR4A1 antagonists. (B) Cells were transfected wit...
<p>HeLa cells were transfected with either the plasmid expressing hnRNPA1 or the equivalent empty ve...
<p>Wildtype and <i>Pink1<sup>−/−</sup></i> MEF were transfected with plasmid pNF-κB-luc (Clontech). ...
<p>(<b>A</b>) PC12 cells were transfected with two plasmids, one expressing recombinant FGFR1 or con...
<p>Luciferase reporter bearing 3 copies of ARE (<b>A</b>)<b>,</b> or GCLM-luciferase reporter (<b>B<...
<p>(<b>A</b>) Schematic of the experimental design. B1 and B2 SINE expression constructs were co-tra...
Several gene therapy applications require the transfer and simultaneous expression of multiple genes...
<p>C2C12 cells were first transfected with bicistronic plasmids and 48h later with siRNAs targeting ...
<p>(A) RT qPCR quantification of endogenous FGF1 mRNA A was performed as described in Mat. & Meth. d...
<p>C2C12 cells were transfected with bicistronic plasmids containing either the complete promoter 1A...
<p>(A, C, E) C2C12 cells were transfected with bicistronic plasmids containing either the FGF1 IRES,...
<p>A) Vero cells were co-transfected with the NF-κB reporter and either each of the different PB1-F2...
<p>(A, B) Suppression of co-transfected reporters in HeLa cells (A) and mouse 3T3 cells (B). Cells w...
<p>(<b>A–B</b>) Relative NF-κB activity after co-transfection of pNF-κB-Luc and p22-FLIP plasmid wit...
<p>(<b>A, B, C, D and E</b>) The fluorescent images were captured of cells transfected with either v...
<p>(A) Pathways activated by NR4A1 and targeted by NR4A1 antagonists. (B) Cells were transfected wit...
<p>HeLa cells were transfected with either the plasmid expressing hnRNPA1 or the equivalent empty ve...
<p>Wildtype and <i>Pink1<sup>−/−</sup></i> MEF were transfected with plasmid pNF-κB-luc (Clontech). ...
<p>(<b>A</b>) PC12 cells were transfected with two plasmids, one expressing recombinant FGFR1 or con...
<p>Luciferase reporter bearing 3 copies of ARE (<b>A</b>)<b>,</b> or GCLM-luciferase reporter (<b>B<...
<p>(<b>A</b>) Schematic of the experimental design. B1 and B2 SINE expression constructs were co-tra...
Several gene therapy applications require the transfer and simultaneous expression of multiple genes...